In particular, the current simulations strongly support that TAD cancer mutants can significantly modulate the unbound conformational ensembles, which could in turn disturb the balance between binding to MDM2 and CBP and further alter how the balance is regulated by multisite phosphorylation of TAD. The gene discussed is MDM2; the disease is cancer.